Among these 7 datasets, three studies had data on the prefrontal cortex, two of which showed a significantly higher Sema3D level in the AD patients (p < 0.001) and one smaller study yielded an odd ratio of 1.41 without reaching significance level of 0.05 (Table 2). The gene discussed is SEMA3D; the disease is Alzheimer disease.